FDA Inspection 868663 — Adventhealth Sebring

Adventhealth Sebring — FEI 3003913121

The FDA completed an inspection of Adventhealth Sebring on Mar 21, 2014 in Sebring, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 21, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sebring, FL (United States)

Citations

IDCFRDescription
14421 CFR 606.140(c)Adequate identification and handling of test samples
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.